S-3384 : Still Just a Bill


Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020

This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.

Action Timeline

Action DateTypeTextSource
2020-03-03IntroReferralRead twice and referred to the Committee on Finance.Senate
2020-03-03IntroReferralIntroduced in SenateLibrary of Congress

Sponsor :

Martha McSally [R] (AZ)
See Cosponsors

Policy Area :

Health
Related Subjects
  • Administrative law and regulatory procedures
  • Administrative remedies
  • Business ethics
  • Civil actions and liability
  • Competition and antitrust
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Health care costs and insurance
  • Health information and medical records
  • Inflation and prices
  • Intellectual property
  • Licensing and registrations
  • Manufacturing
  • Medicare
  • Prescription drugs
  • Public participation and lobbying
  • Trade restrictions
Related Geographic Entities
  • Canada
Related Organizations
  • Department of Health and Human Services
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)

Related Bills

See Related Bills